In    Kenya,    the    bacterial    infections    that    contribute    most    to    human    disease    are    often    those    in    which    re-‐sistance    is    most    evident.    Examples    are    multidrug-‐resistant    enteric    bacterial    pathogens    such    as    typhoid,  ...  diarrhoeagenic    Escherichia    coli    and    invasive    non-‐typhi    salmonella,    penicillin-‐resistant    Streptococcus    pneu-‐moniae,    vancomycin-‐resistant    enterococci,    methicillin-‐resistant    Staphylococcus    aureus    and    multidrug-‐re-‐sistant    Mycobacterium    tuberculosis.    Resistance    to    medicines    commonly    used    to    treat    malaria    is    of    particu-‐lar    concern,    as    is    the    emerging    resistance    to    anti-‐HIV    drugs.    Often,    more    expensive    medicines    are    required    to    treat    these    infections,    and    this    becomes    a    major    challenge    in    resource-‐poor    settings.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This factsheet describes the work and activities of the Center for Disease Control and Prevention (CDC) in Mozambique as well as its impact in this country. 
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                October 2009 | Volume 6 | Issue 10 | e1000162
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                PLOS ONE | DOI:10.1371/journal.pone.0172392 February 16, 2017 
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The U.S. President‘s Emergency Plan for AIDS Relief
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Supplement Article 
www.jaids.com J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Background: Evidence based treatment interventions for young people with first-episode psychosis (FEP) and trauma histories is lacking. Although case formulation (CF) has been widely regarded in cognitive behavioural therapy manuals as beneficial, there is limited empirical research examining how cl...ients and therapists experience the process. Aim: This study aimed to explore young people’s reactions to CF in treatment for PTSD (post-traumatic stress disorder) and FEP
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...ve to asthma prevalence. This is particularly true for many countries in sub-Saharan Africa. Although inhaled asthma treatments (particularly those containing inhaled corticosteroids) markedly reduce asthma morbidity and mortality, a substantial proportion of the children, adolescents, and adults with asthma in LMICs do not get to benefit from these, due to poor availability and affordability. In this review, we consider the reality faced by clinicians managing asthma in the primary and secondary care in sub-Saharan Africa and suggest how we might go about making diagnosis and treatment decisions in a range of resource-constrained scenarios. We also provide recommendations for research and policy, to help bridge the gap between current practice in sub-Saharan Africa and Global Initiative for Asthma (GINA) recommended diagnostic processes and treatment for children, adolescents, and adults with asthma.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over... the world – and thereby also the need for dialysis. Unfortunately, the prevalence increases most rapidly in lowand middle-income countries. Globally, there are great inequities in access and quality of management of kidney failure. Many low- and middle-income countries cannot meet the increased need for dialysis. If the patients receive dialysis, it might only be for a limited period due to the out-of-pocket expenses. There are global disparities in CKD mortality reflecting the disparities in access to care. Lack of access to dialysis is an important cause of the increased CKD mortality in low- and middle-income countries.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                front cover © Hannah Maule-Ffinch/Save the Children
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Frontiers in Pediatrics | www.frontiersin.org
1 April 2019 | Volume 7 | Article 159
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                How to successfully apply for, administer, and manage the Zithromax® donation for trachoma elimination
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                2023 was another year of significant progress in the fight against HIV, tuberculosis (TB) and malaria. In countries where the Global 
Fund invests, there has been a full recovery from the disruptive impact of the COVID-19 pandemic. The results we have achieved in the last year build on our extraord...inary track record of progress. Over the last two decades, our partnership has cut the combined death rate from AIDS, TB and malaria by 61%. As of the end of 2023, the Global Fund partnership has saved 65 million lives.
                                                                    more